These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35945463)

  • 1. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
    Lucas CG; Sloan EA; Gupta R; Wu J; Pratt D; Vasudevan HN; Ravindranathan A; Barreto J; Williams EA; Shai A; Whipple NS; Bruggers CS; Maher O; Nabors B; Rodriguez M; Samuel D; Brown M; Carmichael J; Lu R; Mirchia K; Sullivan DV; Pekmezci M; Tihan T; Bollen AW; Perry A; Banerjee A; Mueller S; Gupta N; Hervey-Jumper SL; Oberheim Bush NA; Daras M; Taylor JW; Butowski NA; de Groot J; Clarke JL; Raleigh DR; Costello JF; Phillips JJ; Reddy AT; Chang SM; Berger MS; Solomon DA
    Acta Neuropathol; 2022 Oct; 144(4):747-765. PubMed ID: 35945463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded analysis of high-grade astrocytoma with piloid features identifies an epigenetically and clinically distinct subtype associated with neurofibromatosis type 1.
    Cimino PJ; Ketchum C; Turakulov R; Singh O; Abdullaev Z; Giannini C; Pytel P; Lopez GY; Colman H; Nasrallah MP; Santi M; Fernandes IL; Nirschl J; Dahiya S; Neill S; Solomon D; Perez E; Capper D; Mani H; Caccamo D; Ball M; Badruddoja M; Chkheidze R; Camelo-Piragua S; Fullmer J; Alexandrescu S; Yeaney G; Eberhart C; Martinez-Lage M; Chen J; Zach L; Kleinschmidt-DeMasters BK; Hefti M; Lopes MB; Nuechterlein N; Horbinski C; Rodriguez FJ; Quezado M; Pratt D; Aldape K
    Acta Neuropathol; 2023 Jan; 145(1):71-82. PubMed ID: 36271929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
    Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
    Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
    Fisher MJ; Jones DTW; Li Y; Guo X; Sonawane PS; Waanders AJ; Phillips JJ; Weiss WA; Resnick AC; Gosline S; Banerjee J; Guinney J; Gnekow A; Kandels D; Foreman NK; Korshunov A; Ryzhova M; Massimi L; Gururangan S; Kieran MW; Wang Z; Fouladi M; Sato M; Øra I; Holm S; Markham SJ; Beck P; Jäger N; Wittmann A; Sommerkamp AC; Sahm F; Pfister SM; Gutmann DH
    Acta Neuropathol; 2021 Apr; 141(4):605-617. PubMed ID: 33585982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.
    Ammendola S; Broggi G; Barresi V
    Histol Histopathol; 2023 Jul; 38(7):739-753. PubMed ID: 36651583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscape of gliomas arising after therapeutic radiation.
    López GY; Van Ziffle J; Onodera C; Grenert JP; Yeh I; Bastian BC; Clarke J; Oberheim Bush NA; Taylor J; Chang S; Butowski N; Banerjee A; Mueller S; Kline C; Torkildson J; Samuel D; Siongco A; Raffel C; Gupta N; Kunwar S; Mummaneni P; Aghi M; Theodosopoulos P; Berger M; Phillips JJ; Pekmezci M; Tihan T; Bollen AW; Perry A; Solomon DA
    Acta Neuropathol; 2019 Jan; 137(1):139-150. PubMed ID: 30196423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
    Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
    AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.
    Gutmann DH; James CD; Poyhonen M; Louis DN; Ferner R; Guha A; Hariharan S; Viskochil D; Perry A
    Neurology; 2003 Nov; 61(10):1397-400. PubMed ID: 14638962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association.
    Palsgrove DN; Brosnan-Cashman JA; Giannini C; Raghunathan A; Jentoft M; Bettegowda C; Gokden M; Lin D; Yuan M; Lin MT; Heaphy CM; Rodriguez FJ
    Mod Pathol; 2018 Dec; 31(12):1787-1800. PubMed ID: 29973652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
    Appay R; Dehais C; Maurage CA; Alentorn A; Carpentier C; Colin C; Ducray F; Escande F; Idbaih A; Kamoun A; Marie Y; Mokhtari K; Tabouret E; Trabelsi N; Uro-Coste E; Delattre JY; Figarella-Branger D;
    Neuro Oncol; 2019 Dec; 21(12):1519-1528. PubMed ID: 31832685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
    Jain S; Gupta P; Shankar KB; Singh R; Siraj F
    J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.
    Nix JS; Yuan M; Imada EL; Ames H; Marchionni L; Gutmann DH; Rodriguez FJ
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):96-107. PubMed ID: 32603552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEGA-like circumscribed astrocytoma in a non-NF1 patient, harboring molecular profile of GBM. A case report.
    Yamada S; Tanikawa M; Matsushita Y; Fujinami R; Yamada H; Sakomi K; Sakata T; Inagaki H; Yokoo H; Ichimura K; Mase M
    Neuropathology; 2024 Jun; 44(3):190-199. PubMed ID: 37919875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
    Fujimoto K; Arita H; Satomi K; Yamasaki K; Matsushita Y; Nakamura T; Miyakita Y; Umehara T; Kobayashi K; Tamura K; Tanaka S; Higuchi F; Okita Y; Kanemura Y; Fukai J; Sakamoto D; Uda T; Machida R; Kuchiba A; Maehara T; Nagane M; Nishikawa R; Suzuki H; Shibuya M; Komori T; Narita Y; Ichimura K
    Acta Neuropathol; 2021 Aug; 142(2):323-338. PubMed ID: 34148105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare NF1 Gene Mutation in Chinese Patient with Neurofibromatosis Type 1 and Anaplastic Astrocytoma.
    Zhou S; Zhu Y; Xu J; Tao R; Yuan S
    World Neurosurg; 2020 Feb; 134():434-437. PubMed ID: 31678437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
    Vizcaíno MA; Shah S; Eberhart CG; Rodriguez FJ
    Hum Pathol; 2015 Sep; 46(9):1323-30. PubMed ID: 26190195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the central nervous system manifestations of neurofibromatosis type 1.
    Nix JS; Blakeley J; Rodriguez FJ
    Acta Neuropathol; 2020 Apr; 139(4):625-641. PubMed ID: 30963251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.